189 related articles for article (PubMed ID: 36368958)
21. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
[TBL] [Abstract][Full Text] [Related]
22. Integrative epigenomic profiling reveal AP-1 is a key regulator in intrahepatich cholangiocarcinoma.
He K; Feng Y; An S; Liu F; Xiang G
Genomics; 2022 Jan; 114(1):241-252. PubMed ID: 34942351
[TBL] [Abstract][Full Text] [Related]
23. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma.
Amornpisutt R; Proungvitaya S; Jearanaikoon P; Limpaiboon T
Tumour Biol; 2015 Jul; 36(7):4973-8. PubMed ID: 25652468
[TBL] [Abstract][Full Text] [Related]
25. Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma.
Uhm KO; Lee ES; Lee YM; Kim HS; Park YN; Park SH
Oncol Res; 2008; 17(4):151-7. PubMed ID: 18773859
[TBL] [Abstract][Full Text] [Related]
26. Novel target genes and a valid biomarker panel identified for cholangiocarcinoma.
Andresen K; Boberg KM; Vedeld HM; Honne H; Hektoen M; Wadsworth CA; Clausen OP; Karlsen TH; Foss A; Mathisen O; Schrumpf E; Lothe RA; Lind GE
Epigenetics; 2012 Nov; 7(11):1249-57. PubMed ID: 22983262
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
[TBL] [Abstract][Full Text] [Related]
28. Loss of ARID1A induces a stemness gene ALDH1A1 expression with histone acetylation in the malignant subtype of cholangiocarcinoma.
Yoshino J; Akiyama Y; Shimada S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Yamaoka S; Tanabe M; Tanaka S
Carcinogenesis; 2020 Jul; 41(6):734-742. PubMed ID: 31665232
[TBL] [Abstract][Full Text] [Related]
29. Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma.
Hu S; Wang X; Wang T; Wang L; Liu L; Ren W; Liu X; Zhang W; Liao W; Liao Z; Zou R; Zhang X
BMC Med Genomics; 2022 Aug; 15(1):185. PubMed ID: 36028818
[TBL] [Abstract][Full Text] [Related]
30. Aldolase A Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion through Promoting Glycolysis.
Li X; Yu C; Luo Y; Lin J; Wang F; Sun X; Gao Y; Tan W; Xia Q; Kong X
Int J Biol Sci; 2021; 17(7):1782-1794. PubMed ID: 33994862
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.
Huang J; Zhang YL; Teng XM; Lin Y; Zheng DL; Yang PY; Han ZG
BMC Cancer; 2007 Jul; 7():126. PubMed ID: 17626620
[TBL] [Abstract][Full Text] [Related]
32. Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma.
Li J; Lu J; Lv S; Sun S; Liu C; Xu F; Sun H; Yang J; Wang X; Zhong X; Lu J
BMC Gastroenterol; 2022 May; 22(1):269. PubMed ID: 35637430
[TBL] [Abstract][Full Text] [Related]
33. Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review).
Yang R; Song Y; Shakoor K; Yi W; Peng C; Liu S
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35302174
[TBL] [Abstract][Full Text] [Related]
34. Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.
Gao Q; Zhao YJ; Wang XY; Guo WJ; Gao S; Wei L; Shi JY; Shi GM; Wang ZC; Zhang YN; Shi YH; Ding J; Ding ZB; Ke AW; Dai Z; Wu FZ; Wang H; Qiu ZP; Chen ZA; Zhang ZF; Qiu SJ; Zhou J; He XH; Fan J
Gastroenterology; 2014 May; 146(5):1397-407. PubMed ID: 24503127
[TBL] [Abstract][Full Text] [Related]
35. Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro.
Kang Q; Cai JB; Dong RZ; Liu LX; Zhang C; Zhang PF; Zou H; Xie N; Zhang L; Zhang XY; Song ZJ; Dong ZR; Hu MY; Huang XY; Zhang XW; Ke AW; Shi GM
J Clin Pathol; 2017 Aug; 70(8):677-683. PubMed ID: 28096273
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
Li H; Zhou ZQ; Yang ZR; Tong DN; Guan J; Shi BJ; Nie J; Ding XT; Li B; Zhou GW; Zhang ZY
Hepatology; 2017 Jul; 66(1):136-151. PubMed ID: 28194813
[TBL] [Abstract][Full Text] [Related]
37. miR-191 Inhibition Induces Apoptosis Through Reactivating Secreted Frizzled-Related Protein-1 in Cholangiocarcinoma.
Kang PC; Leng KM; Liu YP; Liu Y; Xu Y; Qin W; Gao JJ; Wang ZD; Tai S; Zhong XY; Cui YF
Cell Physiol Biochem; 2018; 49(5):1933-1942. PubMed ID: 30235453
[TBL] [Abstract][Full Text] [Related]
38. Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes.
Sekiya S; Suzuki A
J Clin Invest; 2012 Nov; 122(11):3914-8. PubMed ID: 23023701
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of biliary carcinogenesis and growth.
Wise C; Pilanthananond M; Perry BF; Alpini G; McNeal M; Glaser SS
World J Gastroenterol; 2008 May; 14(19):2986-9. PubMed ID: 18494047
[TBL] [Abstract][Full Text] [Related]
40. COTE1 Facilitates Intrahepatic Cholangiocarcinoma Progression via Beclin1-Dependent Autophagy Inhibition.
Zhang H; Chen S; Xu S; Li X
Biomed Res Int; 2023; 2023():5491682. PubMed ID: 37780485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
